Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

SHE:002020 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	403.74	316.27	1,461	1,548	1,561	915.35
Short-Term Investments	-	-	-	-	-	70.21
Trading Asset Securities	294.7	827.66	150.96	366.89	422.4	1,179
Cash & Short-Term Investments	698.43	1,144	1,612	1,915	1,983	2,164
Cash Growth	-67.96%	-29.03%	-15.85%	-3.41%	-8.38%	-14.52%
Accounts Receivable	782.93	852.02	612.58	509.57	510.67	379.93
Other Receivables	32.96	55.26	51.44	59.13	103.81	53.36
Receivables	815.88	907.27	664.02	568.7	614.47	433.29
Inventory	824.78	792.72	652.69	773.7	677.69	500.76
Prepaid Expenses	-	3.36	3.7	2.52	0.81	2.23
Other Current Assets	380.83	57.5	421.56	20.88	17.82	24.35
Total Current Assets	2,720	2,905	3,354	3,281	3,294	3,125
Property, Plant & Equipment	2,106	2,188	2,300	1,632	1,297	1,079
Long-Term Investments	550.13	2,161	1,124	1,134	882.21	681.06
Goodwill	348.48	348.48	348.48	348.48	348.48	257.89
Other Intangible Assets	394.64	382.26	401.26	418.59	157	150.77
Long-Term Deferred Tax Assets	89.54	83.56	80.98	75.11	68.64	43.97
Long-Term Deferred Charges	54.87	58.73	21.2	26.71	55.95	74.03
Other Long-Term Assets	1,723	351.9	356.72	446.73	443.95	254.71
Total Assets	7,987	8,479	7,987	7,363	6,547	5,666
Accounts Payable	749.29	880.79	941.16	719.12	449.79	369.05
Accrued Expenses	153.77	198.28	206.39	187.72	189.47	181.44
Short-Term Debt	190	281.36	279.09	238.58	148.33	300.13
Current Portion of Long-Term Debt	-	-	-	0.05	0.27	-
Current Portion of Leases	12.77	13.3	11.86	14.69	14.66	-
Current Income Taxes Payable	113.2	89.18	44.3	59.99	50.25	56.06
Current Unearned Revenue	41.65	56.48	53.35	81.01	47.61	48.14
Other Current Liabilities	650.25	615.12	538.61	514.23	521.88	592.04
Total Current Liabilities	1,911	2,135	2,075	1,815	1,422	1,547
Long-Term Debt	-	-	-	-	0.04	0.65
Long-Term Leases	22.52	23.13	31.23	42.98	30.62	-
Long-Term Unearned Revenue	272.94	264.59	268.81	270.6	128.73	138.7
Long-Term Deferred Tax Liabilities	55.55	54.33	68.4	59.68	65.44	46.55
Other Long-Term Liabilities	0.98	1.19	3.2	1.94	0.74	0.82
Total Liabilities	2,263	2,478	2,446	2,191	1,648	1,734
Common Stock	861.03	861.03	861.03	861.03	905.32	705.51
Additional Paid-In Capital	1,723	1,723	1,723	1,720	2,236	1,897
Retained Earnings	3,531	3,368	2,914	2,554	2,150	1,766
Treasury Stock	-443.18	-	-	-	-437.62	-458.13
Comprehensive Income & Other	17.08	17.17	13.86	11.31	8.05	6.37
Total Common Equity	5,690	5,970	5,512	5,146	4,862	3,918
Minority Interest	34.12	32.04	27.78	25.85	37.72	15.07
Shareholders' Equity	5,724	6,002	5,540	5,172	4,899	3,933
Total Liabilities & Equity	7,987	8,479	7,987	7,363	6,547	5,666
Total Debt	225.29	317.79	322.18	296.3	193.92	300.77
Net Cash (Debt)	473.15	826.13	1,290	1,619	1,789	1,864
Net Cash Growth	-73.80%	-35.94%	-20.35%	-9.51%	-4.00%	-14.22%
Net Cash Per Share	0.56	0.96	1.50	1.88	2.19	2.34
Filing Date Shares Outstanding	825.93	861.03	861.03	861.03	861.03	807.73
Total Common Shares Outstanding	825.93	861.03	861.03	861.03	861.03	807.73
Working Capital	808.99	770.26	1,279	1,466	1,872	1,578
Book Value Per Share	6.89	6.93	6.40	5.98	5.65	4.85
Tangible Book Value	4,946	5,239	4,763	4,379	4,356	3,509
Tangible Book Value Per Share	5.99	6.08	5.53	5.09	5.06	4.34
Land	-	-0.21	-0.21	-	-	-
Buildings	-	1,629	1,388	934.82	889.16	752.75
Machinery	-	1,754	1,412	1,219	946.45	803.63
Construction In Progress	-	13.62	482.06	284.91	161.34	139.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.